(Q44393910)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21718134%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Population based study of prognostic factors and treatment in adult Burkitt lymphoma: a Swedish Lymphoma Registry study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21718134%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

main subject

Burkitt lymphoma

0 references

adult Burkitt lymphoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21718134%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

4

Mats Jerkeman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21718134%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

3

Hans Hagberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21718134%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Björn Jonsson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21718134%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

1 reference

30 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21718134%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21718134%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21718134%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21718134%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

2090-2096

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21718134%20AND%20SRC:MED&resulttype=core&format=json

Adult Burkitt leukemia and lymphoma

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.593274

Treatment of Burkitt lymphoma in children and adults: Lessons from Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.593274

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.593274

Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.593274

The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.593274

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.593274

Treatment advances in adult Burkitt lymphoma and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.593274

Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.593274

A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.593274

Burkitt lymphoma in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.593274

Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.593274

Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.593274

Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.593274

High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.593274

Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable,

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.593274

10.3109/10428194.2011.593274

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21718134%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference